唾液皮质醇、可的松和地塞米松与血清检测在动态肾上腺功能试验中的比较
该横断面研究在三级转诊中心纳入640例成人,比较动态肾上腺试验中唾液皮质醇、可的松和地塞米松与血清检测的相关性,并推导与临床相关血清皮质醇浓度对应的唾液阈值。结果显示唾液皮质醇和可的松与血清皮质醇相关性良好,唾液地塞米松与血清地塞米松相关,并给出了相应唾液阈值。
要点
- 唾液皮质醇和可的松与血清皮质醇在动态试验中相关性良好。
- 1-mg DST后唾液可的松相关性优于皮质醇(r=0.86 vs 0.53)。
- 推导出与血清皮质醇1.8、5、10、18 µg/dL对应的唾液阈值。
核心结论
- 研究结果支持基于唾液的动态肾上腺试验,并确定了临床相关的唾液阈值。
研究设计与样本
- 横断面研究,在三级转诊中心纳入接受DST(n=473)、CST(n=163)或过夜美替拉酮试验(OMT;n=11)的成人。
- 共640名参与者,分析815对血清和唾液样本;血清皮质醇用免疫法测定,血清和唾液地塞米松、唾液皮质醇和可的松用液相色谱-串联质谱法测定。
主要发现
- 唾液皮质醇和可的松与血清皮质醇在动态试验中相关性良好,1-mg DST后差异最大(可的松r=0.86,皮质醇r=0.53;均P<0.001)。
- CST期间两种分析物的相关性范围为r=0.75-0.87(均P<0.001)。
- 唾液地塞米松与血清地塞米松相关(r=0.61,P<0.001)。
关键数值与推荐
- 与预设临床相关血清皮质醇浓度1.8、5、10、18 µg/dL(50、138、276、497 nmol/L)对应的唾液可的松阈值分别为117、329、585、1262 ng/dL(3.25、9.13、16.23、35.01 nmol/L)。
- 对应的唾液皮质醇阈值分别为16.5、38、80、278 ng/dL(0.46、1.05、2.21、7.67 nmol/L)。
临床怎么用
- 动态肾上腺试验中可考虑采用唾液皮质醇和可的松替代或辅助血清检测。
- 可使用推导的唾液阈值解读与血清皮质醇临床相关浓度对应的结果。
- 唾液地塞米松可用于确认DST期间的暴露。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Salivary cortisol and cortisone provide non-invasive measures of biologically active cortisol, but their performance during dynamic testing remains incompletely defined. The utility of salivary dexamethasone to confirm exposure during dexamethasone suppression testing (DST) is unknown. OBJECTIVE: To compare salivary cortisol, cortisone, and dexamethasone with serum measurements during dynamic adrenal testing and to derive salivary cortisol and cortisone thresholds corresponding to clinically relevant serum cortisol concentrations. DESIGN AND SETTING: Cross-sectional study at a tertiary referral center. PARTICIPANTS: Adults undergoing DST (n = 473), cosyntropin stimulation testing (CST; n = 163), or overnight metyrapone testing (OMT; n = 11). MEASUREMENTS: Serum cortisol was measured by immunoassay. Serum and salivary dexamethasone, salivary cortisol and cortisone were quantified by liquid chromatography-tandem mass spectrometry. RESULTS: Among 640 participants, 815 paired serum and salivary samples were analyzed. Salivary cortisol and cortisone correlated well with serum cortisol across dynamic testing, with the greatest difference following 1-mg DST (r = 0.86 vs 0.53 for cortisone and cortisol, respectively; both P < 0.001). During CST, correlations ranged from r = 0.75-0.87 for both analytes (all P < 0.001). Salivary dexamethasone correlated with serum dexamethasone (r = 0.61, P < 0.001).Salivary cortisone thresholds corresponding to prespecified clinically relevant serum cortisol concentrations of 1.8, 5, 10, and 18 µg/dL (50, 138, 276, and 497 nmol/L) were 117, 329, 585, and 1262 ng/dL (3.25, 9.13, 16.23, and 35.01 nmol/L), respectively; corresponding salivary cortisol thresholds were 16.5, 38, 80, and 278 ng/dL (0.46, 1.05, 2.21, and 7.67 nmol/L). CONCLUSIONS: These findings support saliva-based dynamic adrenal testing and identify clinically relevant salivary thresholds.
引用
- Ahmadian S, Villavicencio Torres CA, Aggarwal E, et al. Comparison of Salivary Cortisol, Cortisone, and Dexamethasone with Serum Measurements Across Dynamic Adrenal Testing. J Clin Endocrinol Metab. 2026. PMID: 42791226. doi:10.1210/clinem/dgag393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。